Viking (VKTX) is in the midst of a phase 2a dosing trial of its oral obesity drug VK2735, with a data readout expected in the second half of the year. The company is expected to launch a phase 3 trial ...
People looking to improve their health and wellbeing are being urged to be cautious of quick fix diet scams and to only rely on trusted health advice sources. Staffordshire County Council’s Trading ...